Blood Center of Southeast Wisconsin

Milwaukee, Wisconsin 53233

0 studies enrolling now · 3 studies all time

What they study most

Acquired Hemophilia A, Hemophilia A With Inhibitors, Von Willebrand Disease

Studies at this site

• A Study to Evaluate Efficacy of rFVIIIFc for Immune Tolerance Induction (ITI) in Severe Hemophilia A Participants With Inhibitors Undergoing the First ITI Treatment (verITI-8 Study) — Completed
• Post-Marketing Non-Interventional Safety Evaluation of Obizur in the Treatment of Bleeding Episodes for Patients With Acquired Hemophilia A — Completed
• Recombinant Von Willebrand Factor in Subjects With Severe Von Willebrand Disease Undergoing Surgery — Completed